In this study, we report a 26-year-old female case of Niemann-Pick disease type C in association with Fuchs heterochromic iridocyclitis who was admitted with the complaint of ocular pain and redness following trauma. She had mild inflammatory signs and also vertical ocular motility limitations.
Introduction
Niemann-Pick disease type C (NP-C) is a rare neurodegenerative disease. [1] Abnormal saccadic eye movements (SEMs) are frequently the earliest neurological sign appreciated in NP-C. In most patients, the initial deficit is in the vertical plane; however, finally, the horizontal plane may be affected too. [2, 3] Fuchs heterochromic iridocyclitis (FHI) is a chronic nongranulomatous disease. Its exact etiology is unknown; however, some associations with many other diseases such as toxoplasmosis, rubella vaccination, herpes simplex virus, cytomegalovirus, retinitis pigmentosa, Usher's syndrome, and previous trauma were explained previously. [4] In this study, we report one case of NP-C in association with FHI.
Case Report
A 26-year-old female with the complaint of ocular pain and redness (in the right eye) following trauma was admitted to ophthalmology emergency room. According to her mother's history, the patient had a medical history of developmental delay, auditory impairment, the history of generalized tonic-clonic seizures, and also ataxic gait since the toddler age and she had some school difficulties since childhood. Furthermore, according to her medical documents, the history of gastroesophageal reflux disease was noted but she had no history of pulmonary or splenic abnormalities. In ocular motility testing, limitation in vertical gazes (both up and down gazes) was found. According to the patient and her mother's history, this problem had existed from childhood, and over the years, it progressed, and she has had difficulties in reading [ Figure 6 ].
Niemann-Pick Disease Type C Associated with Fuchs Heterochromic Iridocyclitis
The paraclinic findings included of complete blood count, serum electrolytes, lipid profile, serum copper and ceruloplasmin, erythrocyte sedimentation rate, C-reactive protein, serum transaminases, urea, creatinine, and blood urea nitrogen were in the normal range. Furthermore, serum antinuclear and antiphospholipid antibodies were negative. Purified protein derivative skin test, rapid plasma reagin test, and Venereal Disease Research Laboratory test were also negative. Chest X-ray was normal.
A magnetic resonance imaging (MRI) was done before in which cerebellar atrophy was reported [ Figure 7 ]. Furthermore, it was cleared that her cousin had similar neurologic and ocular motility findings; however, no other similar findings were reported in her family. The patient's parents did not have any relationship.
Discussion
NP-C disease has several neurologic, cognitive, and ocular manifestations and is linked with the autosomal recessive inheritance of mutations of the genes, NPC1 and NPC2. [5] About the ophthalmic abnormalities, these patients do not have retinal pigment abnormalities or cherry-red spot. However, abnormal SEM is often present as the initial neurological abnormality in NP-C. In the majority of patients, the primary SEM deficit is in the vertical plane, which results in difficulties in downward, upward, and eventually both gazes. After that, the horizontal gazes are disturbed too. Subsequently, these changes cause complete supranuclear gaze palsy and so the limitation of patients in reading and following the targets. According to the previous studies, vertical supranuclear gaze palsy is known as the prominent sign of NP-C which is usually diagnosed in the late infantile period and after that. [2, 3] Neuropsychiatric manifestations are commonly diagnosed from the late infantile period and after that. Young patients (especially 6-15 years) sometimes have difficulties at school and/or behavioral problems as reported in our patient. In the majority of patients, the progressive cognitive decline is common. Some of the other neurologic problems included of abnormal muscle tone or posture, incoordination, limited working ability, and seizures or cataplexy are known.
Laboratory biochemistry profiles including blood biochemistry, plasma lipids, and unconjugated bilirubin are commonly normal in NP-C patients, but can be changed in those with hypersplenism or cholestatic liver disease. Low HDL-C is communal. A mild thrombocytopenia can occasionally be detected in patients with splenomegaly. Plasma transaminases are mostly normal; however, aspartate aminotransferase can be elevated but generally returns to normal. [1] Plasma chitotriosidase seems to be a marker for severity of the disorder; however, its usefulness is not proven and also it is neither sensitive nor specific. Anyway, laboratory tests for NP-C are not forthright. Many different biochemical and molecular approaches are suggested for diagnosis, but none of them is exact. In the meantime, the diagnosis is suggested on the basis of physical examination and signs of the disease and ruling out of other differential diagnoses. The exact diagnostic evaluations done in patients assumed to have NP-C can depend on the regional availability of resources and expertise. [1] MRI could reveal some findings such as cerebral atrophy and/or marked atrophy of the superior or anterior cerebellar vermis. Some of the patients may show some small degrees of cerebral atrophy or thinning of the corpus callosum. Furthermore, some of them may have white matter signal hyperintensity lesions in T2-weighted MRIs. [6] Until lately, there was no disease-modifying treatment for NP-C. Helpful therapies are variably effective for the lessening of clinical appearances of this disease. Palliative pharmacotherapy is used for dystonia, seizures, sleep disorders, gastrointestinal symptoms, and rarely, lung involvement. [1] In the meantime, our patient was only treated by anticonvulsant therapy and sometimes proton pump inhibitors such as Omeprazole.
The incidence of FHI is about 0.2% and consists of about 6% of all uveitis patients. [7] In this case, the patient had been followed for about 3 years, and all the immunologic and infectious evaluations were negative during this period. Hence, according to ocular signs and symptoms, the diagnosis of FHI was suggested. The patient was not treated for her FHI disease as it seemed to be controlled; however, reassurance was done about her traumatic findings.
Conclusion
Here, a case of NP-C disease who suffered also from FHI is presented, and hence, it could be added to the long list of FHI associations.
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